English

AXYS PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2001-11-14

25 filing records in this dataset, filed from 1996-05-20 to 2001-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.2 million USD

2000-09-30 · USD

Exact inputs and evidence

Revenue: 3200000 USD Source

Operating margin

-213.59%

2000-09-30 · %

Exact inputs and evidence

Operating Income: -6835000 USD Source
Revenue: 3200000 USD Source

Cash and cash equivalents: 6.65 million USD 2001-09-30 Source
Exact value

6653000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-49.1 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Net income: 9856000 USD · 2000-01-01 – 2000-12-31 Source
Net income: 6185000 USD · 2000-01-01 – 2000-09-30 Source
Net income: -18058000 USD · 2001-01-01 – 2001-03-31 Source
Net income: -13409000 USD · 2001-04-01 – 2001-06-30 Source
Net income: -21315000 USD · 2001-07-01 – 2001-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-11-14.

Financial data available through: 2000-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 1998-12-31
Operating income: 7 of 11 periods available· newest 2000-12-31
Net income: 7 of 11 periods available· newest 2000-12-31
operating cash flow: No compatible figures in this window
Capital expenditure: 7 of 11 periods available· newest 2000-12-31
Total assets: 7 of 11 periods available· newest 2000-12-31
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 2000-12-31
Current liabilities: 6 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 58.62 million

Prior period

−USD 48.76 million

1999-01-01 – 1999-12-31
Current period

USD 9.86 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

9856000 − -48763000 = 58619000 USD

-48763000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
9856000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AXYS PHARMACEUTICALS INC · 2000-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Year-over-year change in Net income: 58619000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 9856000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2761 Input fundies:NetIncome: -48763000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2761
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-55%

Prior period

USD 8.86 million

1999-01-01 – 1999-12-31
Current period

USD 3.99 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

3990000 − 8862000 = -4872000 USD

8862000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
3990000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AXYS PHARMACEUTICALS INC · 2000-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Year-over-year change in Capital expenditure: -4872000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3990000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2795 Input fundies:CapitalExpenditure: 8862000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2795
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Operating cash flow.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1998-01-01 – 1998-12-31

Revenue USD 47.42 million 100% of revenue
Cost of revenue USD 2.06 million 4.3% of revenue
Operating expenses USD 195.8 million 413% of revenue
Other operating costs Derived USD 9.6 million 20% of revenue
Operating income −USD 160.04 million −337% of revenue
Tax, interest and other Derived −USD 3.92 million −8.3% of revenue
Net income −USD 156.12 million −329% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure USD 8.26 million 17% of revenue
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Operating loss: operating costs were 139% of revenue.
1997 Operating loss: operating costs were 154% of revenue.
1998 Operating loss: operating costs were 437% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1996-01-01 – 1996-12-31	21560000	29958000 Derived	-8398000	-2470000 Derived	-5928000	Unavailable	Source 1996-01-01 – 1996-12-31: 21560000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -8398000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -5928000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: 6881000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	24814000	38203000 Derived	-13389000	-2422000 Derived	-10967000	Unavailable	Source 1997-01-01 – 1997-12-31: 24814000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -13389000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -10967000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: 6297000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	47422000	207463000 Derived	-160041000	-3917000 Derived	-156124000	Unavailable	Source 1998-01-01 – 1998-12-31: 47422000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -160041000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -156124000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 8263000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 47.4M 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Revenue	21560000	Revenue: 21560000 Open source
19971997-12-31	Revenue	24814000	Revenue: 24814000 Open source
19981998-12-31	Revenue	47422000	Revenue: 47422000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

91.1% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Year over year	No prior comparable period	Revenue: 21560000 Open source
19971997-12-31	Year over year	15.1%	Revenue: 24814000 Open source Revenue: 21560000 Open source
19981998-12-31	Year over year	91.1%	Revenue: 47422000 Open source Revenue: 24814000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -337.5% 1998

Net margin -329.2% 1998

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Operating margin	-39%	Operating Income: -8398000 Open source Revenue: 21560000 Open source
19971997-12-31	Operating margin	-54%	Operating Income: -13389000 Open source Revenue: 24814000 Open source
19981998-12-31	Operating margin	-337.5%	Operating Income: -160041000 Open source Revenue: 47422000 Open source
19961996-12-31	Net margin	-27.5%	Net Income: -5928000 Open source Revenue: 21560000 Open source
19971997-12-31	Net margin	-44.2%	Net Income: -10967000 Open source Revenue: 24814000 Open source
19981998-12-31	Net margin	-329.2%	Net Income: -156124000 Open source Revenue: 47422000 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 21560000 Open source Capital Expenditure: 6881000 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 24814000 Open source Capital Expenditure: 6297000 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 47422000 Open source Capital Expenditure: 8263000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Operating cash flow	Not reported	No source recorded
19971997-12-31	Operating cash flow	Not reported	No source recorded
19981998-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Free cash flow	Unavailable	Capital Expenditure: 6881000 Open source
19971997-12-31	Free cash flow	Unavailable	Capital Expenditure: 6297000 Open source
19981998-12-31	Free cash flow	Unavailable	Capital Expenditure: 8263000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Liabilities / assets	Not reported	Total Assets: 80832000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 73584000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 107262000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.7× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Current assets / current liabilities	2.9×	Current Assets: 50060000 Open source Current Liabilities: 17256000 Open source
19971997-12-31	Current assets / current liabilities	4×	Current Assets: 57511000 Open source Current Liabilities: 14363000 Open source
19981998-12-31	Current assets / current liabilities	2.7×	Current Assets: 79805000 Open source Current Liabilities: 29546000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 8.34 million Exact value Exact value: -8339000 USD 1994-01-01 – 1994-12-31: -8339000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXYS PHARMACEUTICALS INC · 1994-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Net Income: -8339000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8339000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000912057-97-011007.txt#1738 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 1.12 million Exact value Exact value: 1115000 USD 1994-01-01 – 1994-12-31: 1115000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXYS PHARMACEUTICALS INC · 1994-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Capital Expenditure: 1115000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1115000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000912057-97-011007.txt#1765 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 23.73 million Exact value Exact value: -23733000 USD 1995-01-01 – 1995-12-31: -23733000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXYS PHARMACEUTICALS INC · 1995-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Net Income: -23733000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23733000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000891618-98-001434.txt#2471 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 3.83 million Exact value Exact value: 3827000 USD 1995-01-01 – 1995-12-31: 3827000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXYS PHARMACEUTICALS INC · 1995-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Capital Expenditure: 3827000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3827000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000891618-98-001434.txt#2500 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 5.93 million Exact value Exact value: -5928000 USD 1996-01-01 – 1996-12-31: -5928000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXYS PHARMACEUTICALS INC · 1996-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Net Income: -5928000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5928000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000891618-99-001302.txt#3258 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 6.88 million Exact value Exact value: 6881000 USD 1996-01-01 – 1996-12-31: 6881000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXYS PHARMACEUTICALS INC · 1996-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Capital Expenditure: 6881000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6881000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000891618-99-001302.txt#3292 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
1997 1997-01-01 – 1997-12-31	−USD 10.97 million Exact value Exact value: -10967000 USD 1997-01-01 – 1997-12-31: -10967000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXYS PHARMACEUTICALS INC · 1997-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Net Income: -10967000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10967000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-00-000466.txt#2841 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 6.3 million Exact value Exact value: 6297000 USD 1997-01-01 – 1997-12-31: 6297000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXYS PHARMACEUTICALS INC · 1997-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Capital Expenditure: 6297000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6297000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-00-000466.txt#2876 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
1998 1998-01-01 – 1998-12-31	−USD 156.12 million Exact value Exact value: -156124000 USD 1998-01-01 – 1998-12-31: -156124000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXYS PHARMACEUTICALS INC · 1998-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Net Income: -156124000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -156124000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2761 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 8.26 million Exact value Exact value: 8263000 USD 1998-01-01 – 1998-12-31: 8263000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXYS PHARMACEUTICALS INC · 1998-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Capital Expenditure: 8263000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8263000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2795 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 48.76 million Exact value Exact value: -48763000 USD 1999-01-01 – 1999-12-31: -48763000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXYS PHARMACEUTICALS INC · 1999-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Net Income: -48763000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -48763000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2761 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 8.86 million Exact value Exact value: 8862000 USD 1999-01-01 – 1999-12-31: 8862000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXYS PHARMACEUTICALS INC · 1999-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Capital Expenditure: 8862000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8862000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2795 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2000 2000-01-01 – 2000-12-31	USD 9.86 million Exact value Exact value: 9856000 USD 2000-01-01 – 2000-12-31: 9856000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AXYS PHARMACEUTICALS INC · 2000-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Net Income: 9856000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9856000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2761 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 3.99 million Exact value Exact value: 3990000 USD 2000-01-01 – 2000-12-31: 3990000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AXYS PHARMACEUTICALS INC · 2000-12-31 AXYS PHARMACEUTICALS INC (edgar:913056) Capital Expenditure: 3990000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/913056/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3990000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/913056/0000950149-01-500340.txt#2795 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

25 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000913056, 913056, edgar:913056

Also known as ARRIS PHARMACEUTICAL CORP/DE/, AXYS PHARMECUETICALS INC

AXYS PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Trailing twelve months

Net income

Company performance

What changed year over year

Net income

Capital expenditure

Where revenue goes

1998 1998-01-01 – 1998-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation